Dihydromyricetin Market Size, Share, Growth, and Industry Analysis, By Types (0.95, 0.98, Others), By Applications Covered (Pharma and Healthcare, Food and Feed Additives, Others), Regional Insights and Forecast to 2033

Dihydromyricetin Market size

The Dihydromyricetin Market was valued at USD 339.1 million in 2024 and is projected to reach USD 353.7 million in 2025, with an estimated growth to USD 495.3 million by 2033, exhibiting a CAGR of 4.3% during the forecast period [2025-2033].

The U.S. dihydromyricetin market holds over 38% share, driven by increasing demand in dietary supplements, pharmaceuticals, and skincare. Rising consumer awareness of natural health benefits and antioxidant properties fuels market expansion in the region.

Dihydromyricetin, a flavonoid derived from Hovenia dulcis, is experiencing rising demand across dietary supplements, pharmaceuticals, functional foods, and cosmetics. The increasing preference for natural and plant-based ingredients is a key driver in market expansion. Advancements in extraction and purification techniques have enhanced product quality and availability. Growing awareness of antioxidant and liver-protective benefits has further fueled adoption. The Asia Pacific region dominates due to its traditional medicinal use, expanding health-conscious population, and rising disposable incomes. The expansion of e-commerce platforms and direct-to-consumer sales channels has significantly boosted market accessibility and product reach.

Dihydromyricetin Market Trends

Dihydromyricetin (DHM), a flavonoid primarily extracted from the Hovenia dulcis tree, has seen notable market developments due to its health benefits, particularly liver protection and antioxidant properties. The Asia Pacific region has become a dominant force in the DHM market, accounting for approximately 30% of the global share in 2023. This dominance is largely due to traditional medicinal use and an increasing consumer shift toward natural health products. North America follows closely, contributing around 35%, driven by rising health consciousness and the demand for natural remedies. Europe holds a share of about 20%, with Latin America and the Middle East & Africa contributing 10% and 5%, respectively.

In terms of product purity, the DHM market shows a strong preference for higher purity levels, with the 0.95 purity grade representing 45% of the market and the 0.98 purity grade making up 40%. The pharmaceutical and healthcare sector leads DHM applications, accounting for 50% of usage, followed by the food and feed additives segment at 35%, while other sectors contribute the remaining 15%.

Several factors are propelling the DHM market, including growing demand for natural products, advances in extraction techniques, and heightened awareness of health benefits. However, challenges such as chemical instability and bioavailability issues still hinder its broader adoption in some industries.

Dihydromyricetin Market Dynamics

DRIVER

"Rising demand for pharmaceuticals"

The demand for dihydromyricetin in the pharmaceutical industry has risen significantly due to its therapeutic benefits. Approximately 50% of the total demand for DHM is driven by the pharmaceutical sector, particularly for liver health supplements and antioxidants. The growing awareness about liver diseases and their link to lifestyle factors has led to a higher consumption of liver-protective products containing DHM. This trend is most prominent in North America, where nearly 40% of DHM used in pharmaceuticals is consumed. The rising adoption of natural remedies is further fueling this growth.

RESTRAINTS

"Limited bioavailability of dihydromyricetin"

The bioavailability of dihydromyricetin remains a significant constraint, limiting its effectiveness in several applications. Around 30% of users in the pharmaceutical and dietary supplement markets report that low absorption rates hinder the full benefits of DHM. Despite advancements in extraction and formulation, approximately 25% of DHM products in the market still face challenges in achieving optimal bioavailability. This issue is particularly noticeable in oral supplements, where absorption rates are approximately 15% lower compared to other natural supplements.

OPPORTUNITY

"Growth in personalized medicines"

The rise of personalized medicine presents a promising opportunity for dihydromyricetin's growth. Approximately 40% of pharmaceutical companies are increasingly focusing on personalized treatments, where DHM’s potential as a natural, tailored solution to health issues is gaining traction. In markets like North America and Europe, personalized health supplements, including DHM, have seen a 25% increase in demand. This trend is driven by advancements in medical research, consumer willingness to adopt customized healthcare solutions, and growing interest in natural alternatives.

CHALLENGE

"Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment"

One of the major challenges in the DHM market is the rising cost of pharmaceutical manufacturing equipment. The cost of producing high-quality DHM, especially in large-scale formulations, has surged by approximately 20% over the last few years due to technological upgrades and stringent regulations. This has led to an increase in product pricing, making it less accessible in emerging markets where price sensitivity is high. The cost of raw materials has also risen by 15%, further affecting the overall affordability and production scale.

Segmentation Analysis

The dihydromyricetin market is segmented based on type and application, each influencing the growth dynamics and demand patterns. In terms of type, the market is divided into various purity grades, with 0.95 and 0.98 purity being the most widely used. The 0.95 grade holds a larger market share due to its affordability and effectiveness in dietary supplements and pharmaceutical formulations. The applications of dihydromyricetin are diverse, ranging from pharmaceuticals and healthcare to food and feed additives. The pharmaceutical sector is the largest consumer, owing to the growing focus on liver health, antioxidants, and natural remedies. Food and feed additives are also significant segments, as the demand for natural ingredients continues to rise. Understanding these segments helps businesses strategize for growth and align product development to meet consumer preferences.

By Type

• 0.95 Purity: The 0.95 purity grade of dihydromyricetin accounts for around 45% of the total market share. It is highly favored in dietary supplements and functional foods due to its cost-effectiveness and adequate potency. The 0.95 grade is commonly used in over-the-counter health supplements aimed at supporting liver function and boosting antioxidants.

• 0.98 Purity: The 0.98 purity grade represents approximately 40% of the market. This grade is known for its higher concentration and is predominantly used in pharmaceutical products requiring higher bioavailability. Consumers seeking premium-quality products for liver health and antioxidant purposes are more inclined toward this purity level.

• Others: Other purity grades, accounting for roughly 15%, are used in niche applications where specific formulation characteristics are required. These grades are often utilized in research and specialized products that cater to smaller markets or experimental treatments.

By Application

• Pharma and Healthcare: The pharmaceutical and healthcare segment is the largest consumer of dihydromyricetin, comprising nearly 50% of the market. DHM is used in liver health supplements, antioxidants, and as an adjunct therapy for various health conditions. This segment is driven by the increasing demand for natural products and the growing awareness of the benefits of dihydromyricetin.

• Food and Feed Additives: Food and feed additives represent approximately 35% of the dihydromyricetin market. The growing preference for natural ingredients in functional foods and beverages has spurred demand in this sector. Dihydromyricetin is increasingly used as an antioxidant and preservative in various food products, including beverages and snacks, due to its health benefits and natural origin.

• Others: The remaining 15% of the market is attributed to other applications, including cosmetics, skincare products, and animal feed. These applications leverage the antioxidant and anti-inflammatory properties of dihydromyricetin, contributing to its versatility across different industries.

Regional Outlook

The dihydromyricetin market displays distinct regional dynamics driven by varying consumer preferences, awareness levels, and industry developments. North America, Europe, and Asia-Pacific lead in market share, with strong growth prospects in other regions like the Middle East & Africa. North America holds a substantial market share due to the growing consumer demand for natural health products, particularly in the pharmaceutical and dietary supplement sectors. Europe follows closely, driven by a preference for natural and functional food ingredients. The Asia-Pacific region exhibits rapid growth, fueled by traditional medicinal use, increasing disposable income, and the rising demand for natural remedies. The Middle East & Africa shows moderate growth, with a growing awareness of the benefits of dihydromyricetin in healthcare and wellness products.

North America

North America represents a significant portion of the dihydromyricetin market, contributing around 35% of the global share. The region's robust pharmaceutical and healthcare sectors, coupled with increasing consumer awareness of the health benefits of dihydromyricetin, are major growth drivers. Natural supplements, particularly those focused on liver health and antioxidants, are in high demand. The United States and Canada are at the forefront, with rising adoption of plant-based and natural health products. Approximately 40% of dihydromyricetin demand in North America is linked to the pharmaceutical sector, while the food and beverage industry accounts for an additional 30%.

Europe

Europe holds a substantial share of the dihydromyricetin market, accounting for approximately 20%. The region has seen increased interest in functional foods, beverages, and dietary supplements that offer natural health benefits. Dihydromyricetin’s antioxidant and liver-supporting properties align with growing consumer trends toward preventive healthcare. The market is also driven by regulations favoring natural ingredients in food and supplements. Countries such as Germany, France, and the UK lead the demand for dihydromyricetin-based products, with the pharmaceutical sector being a key contributor at around 45% of the regional market.

Asia-Pacific

Asia-Pacific is experiencing rapid growth in the dihydromyricetin market, capturing around 30% of the global market share. This growth is largely attributed to the region’s long history of traditional use of Hovenia dulcis in herbal medicine. Countries like China, Japan, and South Korea are major contributors to the demand, driven by an increasing focus on natural health products and dietary supplements. The pharmaceutical sector remains the largest consumer, contributing about 50% of the market share, while food and feed additives follow closely with a 35% share. Rising disposable income and health awareness are key factors propelling the market in this region.

Middle East & Africa

The Middle East & Africa accounts for about 5% of the global dihydromyricetin market. Despite being a smaller market, the region is witnessing an increase in demand for natural and functional products, especially in the pharmaceutical sector. As consumers in countries like the UAE and South Africa become more health-conscious, there is growing interest in natural supplements with proven benefits. The demand for dihydromyricetin in the healthcare sector is expected to rise as awareness of its liver protection and antioxidant properties increases. Food and feed additives in this region are also experiencing steady growth, contributing to the overall market expansion.

LIST OF KEY Dihydromyricetin Market COMPANIES PROFILED

• Xian Sost Biotech

• Wuhan Vanz Pharm

• Xi'an Lyphar Biotech

• Xi'an Natural Field Bio-Technique

• Xian Tonking Biotech

• Yongzhou Huamao Biotechnology

• Xi'an Arisun ChemPharm

• Xi'an Pincredit Bio-Tech

• Chengdu Push Bio-technology

Top companies having highest share

• Xian Sost Biotech: 18% Market Share

• Wuhan Vanz Pharm: 15% Market Share

Technological Advancements

Technological advancements have played a crucial role in the growth and expansion of the dihydromyricetin market. With increasing demand for higher purity and more effective formulations, innovations in extraction methods have significantly improved the quality and yield of dihydromyricetin. Advanced extraction techniques, including ultrasonic-assisted extraction and supercritical fluid extraction, have led to a 25% increase in yield efficiency. These methods allow for the production of dihydromyricetin with higher bioavailability and enhanced therapeutic properties, making it more appealing to both the pharmaceutical and dietary supplement sectors.

Additionally, nanotechnology is gaining traction, especially in the pharmaceutical sector, to improve the bioavailability and solubility of dihydromyricetin. Nanoparticle-based formulations are predicted to increase by approximately 30% in the coming years. These advancements in formulation technologies ensure that the compound is more effectively absorbed into the body, increasing its effectiveness as a liver-protective agent.

In terms of manufacturing, automation and process optimization have led to a 20% reduction in production costs. These improvements are enabling companies to meet growing consumer demand while maintaining product affordability. The increased adoption of green technologies, including eco-friendly solvents and sustainable production methods, is also contributing to the market's long-term growth.

NEW PRODUCTS Development

The dihydromyricetin market has witnessed continuous innovation in new product development, driven by increasing consumer demand for natural, functional ingredients. Approximately 35% of market players are focusing on introducing new dihydromyricetin-based products, particularly in the dietary supplement and pharmaceutical sectors.

Encapsulated dihydromyricetin products, which provide controlled release and enhanced bioavailability, have seen a 25% increase in adoption. These products cater to consumers seeking more efficient and long-lasting health benefits, such as improved liver health and antioxidant effects. New product formulations that combine dihydromyricetin with other plant-based ingredients like curcumin and ginger extract are gaining popularity, with 30% of the market introducing such combinations.

Personalized health supplements, which allow consumers to tailor their intake of dihydromyricetin for specific health needs, have also grown in demand. This segment is expected to capture 20% of the total dihydromyricetin product market. Additionally, the rise of plant-based and organic skincare products that feature dihydromyricetin is another promising area of growth. Around 15% of new product developments are focused on incorporating dihydromyricetin into cosmetic formulations. This reflects the growing trend of using natural, antioxidant-rich ingredients in skincare products.

Recent Developments

• Xian Sost Biotech: In 2023, Xian Sost Biotech launched a new dihydromyricetin extract with 0.98 purity for pharmaceutical applications. This high-quality product aimed at liver health supplements saw a 30% increase in demand due to its enhanced bioavailability and antioxidant properties. The company reported that 45% of the product's production capacity was dedicated to meeting the rising global demand.

• Wuhan Vanz Pharm: In early 2024, Wuhan Vanz Pharm introduced a novel encapsulated dihydromyricetin formulation designed for controlled release. This new product, targeting consumers with specific health needs, received positive feedback, with sales increasing by 20% within the first quarter. Approximately 25% of their new product line is dedicated to innovative formulations like this one.

• Xi'an Lyphar Biotech: Xi'an Lyphar Biotech enhanced its production capabilities in 2023 by adopting supercritical fluid extraction technology, improving the yield of dihydromyricetin by 28%. This technological upgrade positioned the company to meet the growing demand for high-purity extracts, with 35% of their new product offerings aimed at pharmaceutical applications.

• Xi'an Natural Field Bio-Technique: In late 2023, Xi'an Natural Field Bio-Technique partnered with major pharmaceutical companies to co-develop dihydromyricetin-based skincare products. The partnership led to a 15% increase in the use of dihydromyricetin in cosmetic formulations, with a strong focus on natural antioxidants for anti-aging and skin repair, driving further growth in this niche market.

• Yongzhou Huamao Biotechnology: In 2024, Yongzhou Huamao Biotechnology expanded its product portfolio by adding organic dihydromyricetin powder for food and beverage applications. The company reported a 10% growth in this segment, as consumer demand for organic, plant-based food ingredients continued to rise. This move contributed to 20% of the company’s growth in the past year.

REPORT COVERAGE

The dihydromyricetin market report offers comprehensive coverage of the market's key trends, segmentation, and dynamics. It includes an analysis of market size and share, highlighting the importance of various regions, types, and applications. The report provides insights into Asia Pacific, the leading region with approximately 30% of the market share, driven by traditional use and rising health awareness. It also explores the North American market, accounting for 35% of global consumption, where demand for natural health products is growing.

The report covers market segmentation by purity, with the 0.95 purity grade representing 45% of the market, and the 0.98 purity grade holding 40% of the share, reflecting the preference for higher-quality products in the pharmaceutical sector. Additionally, the report delves into application categories, with the pharmaceutical and healthcare sector being the dominant consumer at 50%, followed by food and feed additives, contributing 35%.

Further, the report analyzes technological advancements in extraction and formulation techniques, noting a 25% increase in yield efficiency through ultrasonic-assisted extraction and supercritical fluid extraction methods. It also highlights recent product developments, such as the growth of encapsulated dihydromyricetin products, which have seen a 25% rise in adoption. The opportunity in personalized medicine and the challenges related to bioavailability are discussed in detail, providing a balanced view of the market's future outlook.